Article Information
History
- April 30, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ananya Malhotra1,*,
- Erick S. Zepeda2,
- Petra C. Vinke2,
- Geertruida H. de Bock2,
- Willemijn Maas2,
- T. Jeroen. N. Hiltermann3,
- Bernard Rachet1,
- Clémence Leyrat4 and
- Manuela Quaresma1
- 1Inequalities in Cancer Outcomes Network, Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, United Kingdom
- 2Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
- 3Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
- 4Inequalities in Cancer Outcomes Network, Department of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, United Kingdom
- ↵*Corresponding author: Dr Ananya Malhotra, Inequalities in Cancer Outcomes Network, Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, United Kingdom, +44 7415682644, Ananya.Malhotra{at}lshtm.ac.uk (AM)
Posted April 30, 2024.
Changes in Global Quality of Life after treatment with immune checkpoint inhibitors in patients with advanced stage lung cancer in the Netherlands – a 2015-2021 cohort study
